38 results
Page 2 of 2
8-K
t5scichgz
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
wcv8howgs1ya3mweakbg
28 Feb 19
Entry into a Material Definitive Agreement
10:17am
10-K
5ovp wzl7nxw2tu5
19 Mar 18
Annual report
12:00am
10-Q
kajcl1mjrr66pe
20 Dec 17
Quarterly report
12:00am